Economics
Prognosis
Therapy
Bleeding
Heparin
LMWH
Warfarin
|
|
-
Anticoagulation
- a multicomponent intervention does not clearly reduce major bleeding in the elderly
-
| Level of evidence 1b- |
Expiry Date
October 2003 |
-
Anticoagulation
- primary-care based management was as safe and effective as hospital-based management.
-
| Level of evidence 1b |
Expiry Date
October 2003 |
-
Anticoagulation
- biological prosthetic heart valve: fewer bleeds on less intensive INR.
-
| Level of evidence 1b |
Expiry Date June 2002 |
-
Anticoagulation
- guidelines and consultation reduced bleeds and venous thromboembolism.
-
| Level of evidence 1b |
Expiry Date June 2002 |
-
Atrial fibrillation
- DC cardioversion: anticoagulation reduced embolic events.
-
| Level of evidence 4 |
Expiry Date November 2001 |
-
Cardioversion
- anticoagulation reduced embolic events.
-
| Level of evidence 4 |
Expiry Date June 2002 |
-
Myocardial Infarction
- anticoagulation therapy prevents mural thrombi.
-
| Level of evidence 1a |
Expiry Date December 2001 |
-
Pulmonary embolism
- anticoagulation reduced mortality and recurrence.
-
| Level of evidence 1b |
Expiry Date October 2005 |
-
Stroke
- immediate anticoagulation had no clear effect on recurrent embolic stroke.
-
| Level of evidence 1b- |
Expiry Date June 2001 |
|